BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 9400995)

  • 1. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
    Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
    Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo.
    Sato K; Yamazaki K; Shizume K; Kanaji Y; Obara T; Ohsumi K; Demura H; Yamaguchi S; Shibuya M
    J Clin Invest; 1995 Sep; 96(3):1295-302. PubMed ID: 7657804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines.
    Viglietto G; Maglione D; Rambaldi M; Cerutti J; Romano A; Trapasso F; Fedele M; Ippolito P; Chiappetta G; Botti G
    Oncogene; 1995 Oct; 11(8):1569-79. PubMed ID: 7478581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
    Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
    J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
    Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
    Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
    Landgren E; Schiller P; Cao Y; Claesson-Welsh L
    Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast.
    Shore VH; Wang TH; Wang CL; Torry RJ; Caudle MR; Torry DS
    Placenta; 1997 Nov; 18(8):657-65. PubMed ID: 9364601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
    Park JE; Chen HH; Winer J; Houck KA; Ferrara N
    J Biol Chem; 1994 Oct; 269(41):25646-54. PubMed ID: 7929268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
    Taylor AP; Osorio L; Craig R; Raleigh JA; Ying Z; Goldenberg DM; Blumenthal RD
    Clin Cancer Res; 2002 Apr; 8(4):1213-22. PubMed ID: 11948135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.
    Clauss M; Weich H; Breier G; Knies U; Röckl W; Waltenberger J; Risau W
    J Biol Chem; 1996 Jul; 271(30):17629-34. PubMed ID: 8663424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor receptors in smooth muscle cells.
    Ishida A; Murray J; Saito Y; Kanthou C; Benzakour O; Shibuya M; Wijelath ES
    J Cell Physiol; 2001 Sep; 188(3):359-68. PubMed ID: 11473363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
    J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.
    Brogi E; Schatteman G; Wu T; Kim EA; Varticovski L; Keyt B; Isner JM
    J Clin Invest; 1996 Jan; 97(2):469-76. PubMed ID: 8567969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence and possible role of vascular endothelial growth factor in thyroid cell growth and function.
    Wang JF; Milosveski V; Schramek C; Fong GH; Becks GP; Hill DJ
    J Endocrinol; 1998 Apr; 157(1):5-12. PubMed ID: 9614352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea.
    Endo T; Kitajima Y; Nishikawa A; Manase K; Shibuya M; Kudo R
    Fertil Steril; 2001 Oct; 76(4):762-8. PubMed ID: 11591411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
    Barleon B; Siemeister G; Martiny-Baron G; Weindel K; Herzog C; Marmé D
    Cancer Res; 1997 Dec; 57(23):5421-5. PubMed ID: 9393770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
    Khaliq A; Dunk C; Jiang J; Shams M; Li XF; Acevedo C; Weich H; Whittle M; Ahmed A
    Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat.
    Xie B; Tam NN; Tsao SW; Wong YC
    Br J Cancer; 1999 Dec; 81(8):1335-43. PubMed ID: 10604730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.